Anavex Life Sciences Corp. ist eine Aktie aus dem Premium-Bereich von aktien.guide. Bitte anmelden, um einen Alarm für Anavex Life Sciences Corp. zu aktivieren.
Kostenlos registrieren
Bitte registriere Dich kostenlos, um Anavex Life Sciences Corp. zu Deinem Portfolio hinzuzufügen.
Strengthening Operational Efficiency and Execution towards Sustainable Accessibility for Diverse Populations within Global Healthcare Systems Strengthening Operational Efficiency and Execution towards Sustainable Accessibility for Diverse Populations within Global Healthcare Systems
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsychiatric disorders including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia, and other central nervous sys...
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/anavex-life-sciences-lawsuit-submission-form?prid=79635&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/anavex-life-sciences-lawsuit-submission-form?prid=79634&wire=1 or contact Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / May 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or "the Company") (NASDAQ:AVXL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Inv...
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/anavex-life-sciences-lawsuit-submission-form?prid=79615&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/anavex-life-sciences-lawsuit-submission-form?prid=79590&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/anavex-life-sciences-lawsuit-submission-form?prid=79472&wire=1 or contact Joseph E. Levi, Esq.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.